These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3241277)

  • 1. Low-density lipoprotein enhances platelet activation in parallel with the height of blood pressure.
    Fetkovska N; Amstein R; Ferracin F; Bühler FR; Pletscher A
    J Hypertens Suppl; 1988 Dec; 6(4):S646-8. PubMed ID: 3241277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-density lipoprotein amplifies the platelet response to serotonin in human plasma.
    Fetkovska N; Fedelesova V; Dzurik R
    J Hypertens Suppl; 1989 Dec; 7(6):S164-5. PubMed ID: 2632705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of plasma lipoproteins on platelet aggregation in a normal male population.
    Hassall DG; Forrest LA; Bruckdorfer KR; Marenah CB; Turner P; Cortese C; Miller NE; Lewis B
    Arteriosclerosis; 1983; 3(4):332-8. PubMed ID: 6882287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of low density lipoprotein from insulin-dependent diabetic patients on platelet functions.
    Rabini RA; Staffolani R; Martarelli D; Fumelli P; Ravaglia F; Dousset N; Curatola G; Mazzanti L
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3770-4. PubMed ID: 10523028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of platelet desensitization in pregnancy-induced hypertension is dependent on the agonist used.
    Ahmed Y; Sullivan MH; Elder MG
    Thromb Haemost; 1991 May; 65(5):474-7. PubMed ID: 1908139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelets in essential hypertension.
    Nityanand S; Pande I; Bajpai VK; Singh L; Chandra M; Singh BN
    Thromb Res; 1993 Dec; 72(5):447-54. PubMed ID: 8303687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of oxidized low density lipoproteins on ADP-induced platelet aggregation in plasma].
    Vlasova II; Vakhrusheva TV; Azizova OA; Lopukhin IuM
    Vopr Med Khim; 1998; 44(1):43-54. PubMed ID: 9575612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulating effect of biologically modified low density lipoproteins on ADP-induced aggregation of washed platelets persists in absence of specific binding.
    Volf I; Roth A; Moeslinger T; Cooper J; Schmid W; Zehetgruber M; Koller E
    Thromb Res; 2000 Mar; 97(6):441-9. PubMed ID: 10704653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin and platelet activation during treatment with isradipine.
    Fetkovska N; Sebekova K; Fedelesova V; Dzurik R
    J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S31-3. PubMed ID: 1720482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of (E)-4-hydroxy-2-nonenal in platelet activation by low density lipoprotein and iron.
    Selley ML; Bartlett MR; Czeti AL; Ardlie NG
    Atherosclerosis; 1998 Sep; 140(1):105-12. PubMed ID: 9733221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet-activating effect of low-density lipoprotein and its reversal by isradipine.
    Fetkovská N; Fedelesová V; Kozlovský M; Dzúrik R
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):175S-177S. PubMed ID: 1827014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nifedipine reduces thromboxane A2 production by platelets without changing aggregation in hypertensive pregnancy.
    Manninen A
    Pharmacol Toxicol; 1996 Jun; 78(6):387-91. PubMed ID: 8829198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet calcium and quenched-flow aggregation kinetics in essential hypertension.
    Taylor MA; Ayers CR; Gear AR
    Hypertension; 1989 Jun; 13(6 Pt 1):558-66. PubMed ID: 2525522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet dysfunction in uremia. II. Correction by arachidonic acid of the impaired exposure of fibrinogen receptors by adenosine diphosphate or collagen.
    Di Minno G; Cerbone A; Usberti M; Cianciaruso B; Cortese A; Farace MJ; Martinez J; Murphy S
    J Lab Clin Med; 1986 Sep; 108(3):246-52. PubMed ID: 3018111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fosinopril reduces ADP-induced platelet aggregation in hypertensive patients.
    Keidar S; Oiknine J; Leiba A; Shapira C; Leiba M; Aviram M
    J Cardiovasc Pharmacol; 1996 Feb; 27(2):183-6. PubMed ID: 8720415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of low-dose EPA-E on glycemic control, lipid profile, lipoprotein(a), platelet aggregation, viscosity, and platelet and vessel wall interaction in NIDDM.
    Westerveld HT; de Graaf JC; van Breugel HH; Akkerman JW; Sixma JJ; Erkelens DW; Banga JD
    Diabetes Care; 1993 May; 16(5):683-8. PubMed ID: 8495604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modification of protein moiety of human low density lipoprotein by hypochlorite generates strong platelet agonist.
    Volf I; Bielek E; Moeslinger T; Koller F; Koller E
    Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):2011-8. PubMed ID: 10938025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The aggregation of isolated human platelets in the presence of lipoproteins and prostacyclin.
    Hassall DG; Owen JS; Bruckdorfer KR
    Biochem J; 1983 Oct; 216(1):43-9. PubMed ID: 6360159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet alpha 2-adrenoceptors and diurnal changes of platelet aggregability in hypertensive patients.
    Mores N; Martire M; Pistritto G; Volpe AR; Menini E; Folli G; Cardillo C
    J Hypertens; 1994 Aug; 12(8):939-45. PubMed ID: 7814853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoaggregability of washed platelets from stroke-prone spontaneously hypertensive rats (SHRSP).
    Tomita T; Umegaki K; Hayashi E
    Stroke; 1984; 15(1):70-5. PubMed ID: 6420947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.